If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,121.50    27.00 (2.47%)
Bid:
1,121.50
Ask:
1,122.50
Spread: 1.00 (0.089%)
Market Cap: £9.48b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

13 Aug 2025 17:08

RNS Number : 2390V
Smith & Nephew Plc
13 August 2025
 

SMITH & NEPHEW PLC

 

13 August 2025

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

1. VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2020

 

On 13 August 2025, the Company received notification of the following transactions in US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") following the vesting of awards under the Smith & Nephew Global Share Plan 2020.

 

All figures in these columns are stated to 6 decimal places where applicable.

 

 

PARTIAL VESTING OF 2023 CONDITIONAL AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020:

 

The awards were granted under the Global Share Plan 2020 on 11 August 2023. One third of the award vests in equal tranches over the following three years. A number of shares were sold to cover taxation obligations arising on the vesting of the awards.

 

The following relates to individuals included in the below notification:

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Partial vesting on 12 August 2025 of Conditional Share awards granted on 11 August 2023 under the Smith & Nephew Global Share Plan 2020, and subsequent sale of shares to cover tax liability

Date of Transaction

2025 - 08 - 12

Place of Transaction

London Stock Exchange (XLON)

 

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Rohit Kashyap

(President, Advanced Wound Management and Global

PDMR

13.571365

23,201 (of which 5,670 were sold and 17,531 were retained.)

N/A Single Transaction

 

 

 

Helen Barraclough

Company Secretary

Smith & Nephew plc

 

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFIRTEIVLIE
Date   Source Headline
1st Jun 202312:30 pmRNSTotal Voting Rights
24th May 20234:45 pmRNSDirector/PDMR Shareholding
19th May 20234:15 pmRNSDirector/PDMR Shareholding
5th May 20237:08 amRNSDividend Declaration
5th May 20237:00 amRNSDirector Declaration
3rd May 20239:30 amRNSDirector/PDMR Shareholding
2nd May 20231:53 pmRNSTotal Voting Rights
27th Apr 20233:25 pmRNSDirector/PDMR Shareholding
26th Apr 20233:36 pmRNSResult of AGM
26th Apr 20237:00 amRNSQ1 2023 Trading Update
6th Apr 20237:00 amRNSNotice of First Quarter 2023 Trading Report
3rd Apr 20232:07 pmRNSTotal Voting Rights
13th Mar 20231:45 pmRNSDirector/PDMR Shareholding
6th Mar 20236:00 pmRNSAnnual Financial Report
1st Mar 20232:44 pmRNSTotal Voting Rights
22nd Feb 20231:07 pmRNSDirector/PDMR Shareholding
21st Feb 20231:41 pmRNSDirector/PDMR Shareholding
21st Feb 20237:00 amRNSFinal Results
17th Feb 20237:00 amRNSDirectorate Change
1st Feb 20234:15 pmRNSBlock listing Interim Review
1st Feb 202311:20 amRNSTotal Voting Rights
26th Jan 202312:22 pmRNSNotice of Results
19th Jan 20233:19 pmRNSDirector/PDMR Shareholding
3rd Jan 20231:47 pmRNSTotal Voting Rights
12th Dec 20224:37 pmRNSDirector/PDMR Shareholding
9th Dec 202211:30 amRNSDirector/PDMR Shareholding
1st Dec 20222:00 pmRNSTotal Voting Rights
16th Nov 202211:30 amRNSDirector/PDMR Shareholding
10th Nov 20227:00 amRNSDirector/PDMR Shareholding
3rd Nov 20227:00 amRNS3rd Quarter 2022 Trading Report
1st Nov 202210:38 amRNSTotal Voting Rights
28th Oct 202211:45 amRNSDirector/PDMR Shareholding
14th Oct 20227:01 amRNSDividend Declaration
14th Oct 20227:00 amRNSTiming of Smith & Nephew Q3 2022 Trading Update
5th Oct 20227:00 amRNSEuro Bond Issue
3rd Oct 202212:53 pmRNSTotal Voting Rights
14th Sep 20223:00 pmRNSDirector/PDMR Shareholding
1st Sep 20221:33 pmRNSTotal Voting Rights
1st Sep 20227:00 amRNSBoard Committee Membership
23rd Aug 20225:05 pmRNSDirector/PDMR Shareholding
23rd Aug 20224:25 pmRNSDirector/PDMR Shareholding
16th Aug 20224:57 pmRNSDirector/PDMR Shareholding
12th Aug 20225:40 pmRNSTransaction in Own Shares
12th Aug 20224:45 pmRNSDirector/PDMR Shareholding
11th Aug 20226:21 pmRNSTransaction in Own Shares
10th Aug 20226:06 pmRNSTransaction in Own Shares
9th Aug 20226:16 pmRNSTransaction in Own Shares
9th Aug 202211:00 amRNSAdditional Listing
8th Aug 20222:09 pmRNSTransaction in Own Shares
1st Aug 20226:15 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.